Advertisement
Canada markets open in 1 hour 43 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7313
    +0.0016 (+0.22%)
     
  • CRUDE OIL

    82.97
    +0.16 (+0.19%)
     
  • Bitcoin CAD

    87,367.14
    -3,641.25 (-4.00%)
     
  • CMC Crypto 200

    1,357.50
    -25.07 (-1.81%)
     
  • GOLD FUTURES

    2,340.60
    +2.20 (+0.09%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,475.00
    -189.50 (-1.07%)
     
  • VOLATILITY

    16.29
    +0.32 (+2.00%)
     
  • FTSE

    8,090.68
    +50.30 (+0.63%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6821
    +0.0002 (+0.03%)
     

What ResMed’s Valuation Trend Indicates

What ResMed’s Valuation Trend Indicates

Ten analysts covered ResMed (RMD) in September. Four analysts gave ResMed stock a “buy” or higher rating, five analysts gave it a “hold” rating, and one analyst gave it a “strong sell” rating. The mean rating for ResMed stock is 2.6, and its target price is $104.69.